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Objective: Several hundred studies have
shown that depression is associated with
an elevated risk of dying at follow-up. It is
not clear, however, whether the mecha-
nisms for this association are disease
speciﬁc, leading to higher mortality in
speciﬁc patient groups, or generic, result-
ing in comparable mortality rates in all
patient groups as well as in community
samples. The authors conducted a com-
prehensive meta-analysis of prospective
studies of community as well as patient
samples associating depression at baseline
with excess mortality at follow-up.
Method: The authors conducted system-
atic searches of PubMed, PsycINFO, and
Embase. Studies were included if depres-
sion was measured with a standardized
instrument and mortality was reported for
both depressed and nondepressed partic-
ipants at follow-up.
Results: A total of 293 studies including
1,813,733 participants (135,007 depressed
and1,678,726nondepressed) from35coun-
tries were included. The overall unadjusted
relative risk of mortality in depressed re-
lative to nondepressed participants was
1.64 (95% CI=1.56–1.76), with high hetero-
geneity (I2=83, 95% CI=80–84). After ad-
justment for publication bias, the overall
relative risk was reduced to 1.52 (95%
CI=1.45–1.59). No strong indications were
found that the pooled relative risk was
different across the relatively healthy com-
munity samples and speciﬁc patient sam-
ples with heart disease, cancer, kidney
disease, or other disease, except for a sig-
niﬁcantly higher risk in patients with chronic
obstructive pulmonary disease (p,0.05).
Also, the relative risk was lower when the
follow-up period was longer and when the
quality of the study was higher.
Conclusions: The authors could conﬁrm
the presence of a signiﬁcant association
between depression and excess mortality,
although this association may have been
overestimated because of publication bias
and low study quality. Few indications
were found that this association is stronger
in community or speciﬁc patient samples.
Am J Psychiatry Cuijpers et al.; AiA:1–10
After more than 150 years of studies examining the
association between mental disorders and excess mortal-
ity (1, 2), it is well established that mortality rates are
signiﬁcantly elevated in depressed patients. A signiﬁcant
association between depression and excess mortality has
been conﬁrmed in several hundred studies in many
different populations, including community samples (3)
and patients with heart disease (4), cancer (5), stroke (6),
and diabetes (7).
Although no single comprehensive model has yet
described the causal mechanisms linking depression to
excess mortality, several key mechanisms have been
proposed. Some of these are more or less disease speciﬁc.
In cancer research, for example, it has been suggested that
depression-related stressmay have a negative effect on the
cellular processes involved in the repair of damaged DNA
(8) and may accelerate tumor cell growth and promote
tumor migration and invasive capacity (9), which sub-
sequently results in poorer cancer outcomes (10). In heart
disease research, it has been hypothesized that the excess
mortality in depression is associated with factors such as
vascular endothelial dysfunction (11), a prolonged QT
interval (12), lower heart rate variability reﬂecting altered
cardiac autonomic tone (13), and increased platelet
aggregation (11). In addition, in patients with somatic
diseases, depression could have an unfavorable impact on
adherence to a prescribed treatment regimen (14), in turn
having a direct impact on survival.
On the other hand, several of the mechanisms that have
been proposed to mediate the association between
depression and mortality are not speciﬁc to one disease
and may lead to different diseases and multiple pathways
to death. For example, there is evidence suggesting that
dysregulation of central biological stress systems, in-
cluding hypothalamic-pituitary-adrenal axis hyperactivity
(15), neuroimmune dysregulations (16), and sympatho-
adrenergic dysregulation, may have a causal role in the
association between depression and overall mortality (3).
Furthermore, rates of negative lifestyle factors, such as
physical inactivity, smoking, alcohol consumption, and
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unhealthy eating patterns (14), are higher in depressed
patients and may explain part of the association between
depression and mortality, independent of whether an
individual already has a somatic disease.
If excess mortality in depression is caused by disease-
speciﬁc mechanisms, it can be expected thatmortality risks
associated with depression would be higher in depressed
patients than in other patients or community samples.
However, if the excess mortality is more related to generic
factors that are not speciﬁc to one disease, wewould expect
a comparable association between depression and mortal-
ity in any patient or community sample.
To the best of our knowledge, no meta-analytic research
has yet examined whether or not excess mortality in
depression is higher in speciﬁc patient groups. Meta-
analyses are an excellent method for examining this
research question because they can integrate the results of
multiple studies and thereby provide a better estimate of
the true mortality risk of depression across different types
of populations. We conducted a comprehensive meta-
analysis of prospective studies examining the association
between depression at baseline andmortality at follow-up.
We included speciﬁc patient populations as well as the
much healthier community-based samples and any other
study in which the association between depression at
baseline and mortality at follow-up was examined.
Method
Selection of Studies
Studies were identiﬁed by several methods. First, we conducted
comprehensive literature searches (up to April 2013) in three
bibliographical databases—PubMed, PsycINFO, and Embase—
combining terms indicating depression (such as major depres-
sion, mood disorder, depression, depressive), mortality (death,
survival), and prospective design (incidence, follow-up studies,
longitudinal studies, prospective studies). Both text terms and
keywords were used. The detailed search string for our PubMed
search is provided in Appendix A in the data supplement that
accompanies the online edition of this article. We also examined
the references of included studies, as well as the references of
earlier meta-analyses examining the association between de-
pression and mortality (see Appendix B in the data supplement).
We retrieved the full-text papers of studies that possibly met our
inclusion criteria. Full-text papers were examined by two in-
dependent raters for possible inclusion. Disagreements were
resolved by discussion.
We included studies with a prospective design in which
depression was examined at baseline and all-cause mortality
was reported at follow-up. Depression had to be assessed with
a standardized depression measure (either a diagnostic interview
or a self-report questionnaire). We included studies in any target
group (community, patient, and any other sample) as well as
case-control studies. Studies were excluded if insufﬁcient data
were presented to calculate mortality rates at follow-up in the
depressed and nondepressed groups. We excluded studies in
which the instrument for assessing depression was not standard-
ized (e.g., studies relying on self-report of antidepressant use
to assess depression, those using nonstandardized interviews,
and those using only one question), studies based on trials
examining the effects of an intervention, and studies in children
and adolescents.
Data Extraction and Quality Assessment
We assessed the validity of studies with a quality rating scale
based on the instrument developed by Hayden et al. (17). We
adapted the speciﬁc items but retained ﬁve of the six basic areas
of potential bias: study participation (the study sample repre-
sents the population of interest on key characteristics), study
attrition, adequate outcome measurement, adequate measure-
ment of confounding variables, and adequate statistical analysis.
The sixth area of potential bias (the prognostic factor of interest
is adequately measured) was not used because an adequate
measure of depression was used as an inclusion criterion for this
study. The instrument is presented in Appendix C in the online
data supplement, and the ratings for included studies are
presented in Appendix D. Ratings were conducted by two
independent researchers, and disagreements were resolved by
discussion. Agreement between raters after the ﬁrst ratings was
good for four of the ﬁve areas (kappa values for attrition,
outcome measurement, measurement of confounders, and
statistical analysis ranged from 0.69 to 0.78) but was moderate
(0.56) for study participation (18).
To assess excess mortality in different community and patient
groups, we ﬁrst categorized the studies into community sam-
ples and various patient samples by disease. We also rated se-
veral other characteristics of the included studies: deﬁnition of
depression (depression according to a self-report measure or a
diagnostic interview), prevalence of depression, follow-up pe-
riod, type of outcome measure (hazard ratio, relative risk, odds
ratio, or exact numbers of deaths in depressed and nonde-
pressed participants), and country/continent where the study
was conducted.
Meta-Analyses
The included studies used different outcome measures to
characterize the association between depression and mortality.
Some reported the exact number of deaths in the depressed and
nondepressed groups, while others reported the hazard ratio, the
relative risk, or the odds ratio. We used the relative risk as the
main outcome measure (hazard ratio can be considered to be
a speciﬁc type of relative risk adjusted for time to death; the odds
ratio approximates the relative risk when the outcome, in our
case mortality, is 10% or lower, which was the case in most
studies; relative risk was calculated directly when the exact
numbers of deaths per group were reported). In sensitivity
analyses, we examined whether the pooled relative risks
differed for each of these four types of outcome statistics.
To calculate pooled relative risks, we used the computer
program Comprehensive Meta-Analysis, version 2.2.021 (www.
meta-analysis.com). Because we expected considerable hetero-
geneity among the studies, we calculated the pooled relative risk
using a random-effects model.
To examine heterogeneity, we calculated the I2 statistic. A
value of 0% indicates no observed heterogeneity, and larger
values show increasing heterogeneity, with 25% considered low,
50% moderate, and 75% high heterogeneity (19). We calculated
95% conﬁdence intervals around I2 (2, 20) using the noncentral
chi-square-based approach within the heterogi module for Stata
(21). We tested for signiﬁcant heterogeneity with the Q statistic.
Subgroup analyses were conducted according to the mixed-
effects model (22), in which studies within subgroups are pooled
with the random-effects model while tests for signiﬁcant differ-
ences between subgroups are conducted with the ﬁxed-effects
model. Bivariate meta-regression analyses were conducted
according to the procedures implemented in Comprehensive
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Meta-Analysis. Multivariate meta-regression analyses were con-
ducted in Stata, version 11.0 (StataCorp, College Station, Tex.).
Possible publication bias was tested by inspecting the funnel
plot and by Duval and Tweedie’s trim-and-ﬁll procedure (23),
which yields an estimate of the effect size after the publication
bias has been taken into account. We also conducted Egger’s test
of the intercept to quantify the bias captured by the funnel plot
and tested whether it was signiﬁcant.
Results
Selection of Studies
Figure 1 summarizes the study selection process. After
examining a total of 8,275 abstracts (6,252 after removal of
duplicates), we retrieved 1,188 full-text articles for further
consideration. We excluded 895 of the retrieved articles
(reasons for exclusion are provided in Figure 1). A total of
293 studies met inclusion criteria. Characteristics of the
individual studies are provided in Appendix D in the on-
line data supplement (references are listed in Appendix E).
Characteristics of Included Studies
The 293 studies included a total of 1,813,733 respon-
dents, of whom 135,007 were depressed and 1,678,726 were
not depressed (in studies with missing prevalence rates,
we imputed these values with the pooled prevalence rates
of all other studies). Selected characteristics of the 293
studies are presented in Table 1.
The studies were conducted in 35 countries from
all populated continents, although most studies were
conducted in the United States (N=114) and Europe
(N=115). Most studies were conducted in samples
recruited from the general population (N=104), heart
disease patients (N=69), cancer patients (N=29), and
other patient populations (N=84). Depression was es-
tablished by diagnostic interview in 82 studies and by
a self-report measure in 211 studies. Follow-up periods
varied widely; we categorized them as ,1 year (N=56),
1–5 years (N=125), 6–10 years (N=84), and .10 years
(N=38). Most studies were conducted after the year 2000
(N=216). All case-control studies were nested case-
control studies.
The quality of the included studies varied (see Appendix
D in the online data supplement). In the domain of study
participation, 164 studies (56%) scored positive; 186 stud-
ies (64%) scored positive on study attrition, 201 (69%)
on outcome measurement, 121 (41%) on confounding
FIGURE 1. Flowchart of Inclusion of Studies in a Meta-Analysis of Excess Mortality in Depression in Community and Patient
Studies
8,275 references identified 
by literature search:
Pubmed: 4,603
PsychINFO: 1,626
Embase: 2,046
After removal of duplicates:
6,252 abstracts
1,188 publications retrieved
293 studies 
(in 292 papers) included
Excluded: 895
No depression measure (N=241)
Insufficient data to calculate relative risk (N=42)
No data on (overall) mortality (N=172)
No risk of depression on mortality (N=230)
No nondepressed controls (N=38)
Duplicate studies (N=67)
Based on data from a trial (N=64)
Other reason (N=41)
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measurement and account, and 217 (74%) on analyses.
After summing up the individual items, we found that 90
studies (31%) had a total score of 3 or less, 104 (36%)
a score of 3.5–4, and 99 (34%) a score of 4.5–5.
Excess Mortality in Depressed Versus Nondepressed
Participants: Unadjusted Relative Risks
Of the included 293 studies, 238 reported unadjusted
outcomes. The overall unadjusted relative risk of mortality
TABLE 1. Selected Characteristics of Studies Examining the Association Between Depression and Excess Mortality
Studies Respondents
Characteristic N % N %
All studies 293 100.0 1,813,733 100.0
Group
Community samples 104 35.5 1,685,141 92.1
Heart disease patients 69 23.5 43,749 2.4
Cancer patients 29 9.9 10,817 0.6
Kidney disease patients 16 5.5 12,003 0.7
Diabetes patients 8 2.7 28,382 1.6
Chronic obstructive pulmonary disease patients 7 2.4 1,267 0.1
HIV patients 5 1.7 5,637 0.3
Stroke patients 5 1.7 2,380 0.1
Dementia/cognitive decline patients 4 1.4 1,091 0.1
Hip fracture/surgery patients 4 1.4 1,542 0.1
Mixed patient groupsa 18 6.1 7,717 0.4
Other patient groupsb 8 2.7 7,652 0.4
Nursing home residents 9 3.1 4,678 0.3
Case-control studies 7 2.4 1,677 0.1
Deﬁnition of depression
Diagnostic interview 82 28.0 1,130,932 62.4
Self-report measure 211 72.0 682,801 37.6
Follow-up period
#1 year 56 19.1 42,307 2.3
1–2 years 41 14.0 43,254 2.4
3–5 years 84 28.7 254,941 14.1
5–10 years 71 24.2 279,258 15.4
.10 years 38 13.0 1,193,130 65.8
Not reported 3 1.0 843 0.0
Prevalence of depression
,10% 38 13.0 1,241,520 68.5
10%–19% 77 26.3 263,432 14.5
20%–29% 71 24.2 208,806 11.5
30%–40% 40 13.7 23,467 1.3
.40% 44 15.0 22,713 1.3
Not reported 23 7.8 53,795 3.0
Country
United States 114 38.9 430,623 23.7
European countries 115 39.2 1321174 72.8
Other Western countries 26 8.9 36,494 2.0
East Asian countries 25 8.5 18673 1.0
Other countries 13 4.4 6,769 0.4
Publication year
,1990 16 5.5 13,418 0.7
1991–1995 18 6.1 30,296 1.6
1996–2000 43 14.7 63,390 6.5
2001–2005 58 19.8 180,533 9.9
2006–2010 91 31.1 227,647 12.1
2011–2013 67 22.9 1,298,449 69.2
a These were studies of patients with mixed diagnoses admitted to a hospital or to speciﬁc wards or units of a hospital; mixed populations from
inpatient settings (e.g., frail elderly patients; veterans); and mixed patient groups from outpatient clinics.
b In the other patient groups category, we grouped studies of patients with cirrhosis, Parkinson’s disease, rheumatoid arthritis, liver
transplantation, spinal cord injury, or hypertension; patients being weaned from prolonged mechanical ventilation; and elderly patients
discharged from a rehabilitation ward after orthopedic surgery on a lower limb.
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in depressed relative to nondepressed participants in these
238 studies was 1.64 (95% CI=1.56–1.72). Heterogeneity was
high and signiﬁcant (I2=83, 95% CI=80–84). Exclusion of
potential outliers (studies reporting a relative risk $4 or
,0.25) did not reduce heterogeneity and had only a small
effect on the overall relative risk (1.58, 95%CI=1.51–1.65). The
results of these meta-analyses are summarized in Table 2.
After adjustment for publication bias with Duvall and
Tweedie’s trim-and-ﬁll procedure, the overall relative risk
was reduced to 1.52 (95% CI=1.45–1.59; the number of
ﬁlled studies was 41). Egger’s test also pointed toward
signiﬁcant publicationbias (intercept=1.40, 95%CI=1.01–1.81;
p,0.001). A funnel plot with the imputed studies is presented
in Figure 2.
Excess Mortality of Depression in Patient and
Community Samples
We examined the difference in excess mortality between
patient and community samples using subgroup ana-
lyses. We found some indications that the mortality rates
differed among the populations in our meta-analysis
(Table 2; p,0.05). A higher mortality level was found
especially in patients with chronic obstructive pulmonary
disease (COPD). A direct comparison between the studies
of COPD patients and other populations resulted in a
highly signiﬁcant difference (p=0.002). When we removed
the studies of COPD patients from the analyses, the
remaining populations did not differ signiﬁcantly from
each other.
We conducted several additional sensitivity analyses.
First, we excluded the community samples from the
analyses (these studies covered more than 90% of the
total number of participants included in this meta-
analysis; the studies on COPD were not included in these
analyses either). The remaining subgroups of studies did
not differ signiﬁcantly from each other. In another
analysis, we included only the three largest groups of
studies (heart disease, cancer, and kidney diseases) and
found no indication of a signiﬁcant difference between
these groups.
Other Subgroup Analyses
In another series of subgroup analyses, we examined
whether excess mortality was higher in some groups than
in others (Table 2). We found no indication that the
relative risk differed between studies that used different
measures to deﬁne depression (depression according to
a diagnostic interview or self-report measure); studies in
which different outcome statistics were used (relative risk,
hazard ratio, odds ratio, or reported numbers of deaths),
and studies conducted in different parts of the world
(United States, Europe, otherWestern countries, East Asia,
and other countries).
We found that the relative risk was inversely related
to the length of follow-up (p,0.001). We conducted a
bivariate meta-regression analysis with time to follow-up
(as a continuous variable) as predictor and excess mortality
as dependent variable. These analyses also indicated
that time to follow-up was a signiﬁcant predictor of ex-
cess mortality (slope=20.015; 95% CI=20.017 to 20.013;
p,0.000).
We also found that the quality of studies was associated
with relative risk. Higher risk of bias indicated higher
excess mortality of depression. After summing up the
individual items to a total risk of bias score (ranging from 1
[lowest] to 5 [highest]), we conducted a subgroup analysis
of the studies with the lowest to the highest risk of bias. As
can be seen in Table 2, these analyses indicated that the
relative risk was higher in studies with a high risk of bias,
while studies with a lower risk of bias indicated a lower,
although still signiﬁcantly elevated, relative risk (p=0.04).
Multivariate Meta-Regression Analyses
To examine the difference in excess mortality between
the patient and community samples after adjustment
for other characteristics, we conducted a multivariate
meta-regression analysis. We used the relative risk as the
dependent variable and the variables presented in
Table 2 as predictors. As shown in Table 3, the higher
relative risk in studies of COPD patients remained
signiﬁcant in these analyses. None of the other types of
patient or community samples were signiﬁcant after
adjustment for the other characteristics of the studies. We
also found that the two other variables that were
signiﬁcant in the subgroup analyses (time to follow-up
and risk of bias) remained signiﬁcant in the multivariate
analyses.
We also conducted a (manual) back-stepmeta-regression
analysis, in which we dropped the least signiﬁcant variable
in each step until only signiﬁcant predictors were retained
in the model (Table 3). The results of this parsimonious
model indicated that the three variables that were found
to be signiﬁcant in the full multivariate meta-regression
analysis (COPD patients, time to follow-up, and risk of
bias) remained signiﬁcant.
Analyses of Adjusted Outcomes
A considerable number of studies reported the associ-
ation between depression and excess mortality after
adjustment for confounders. To pool the results of studies
with adjusted outcomes, we grouped the studies reporting
adjusted outcomes into four categories in which the
relative risk was 1) adjusted for demographic variables;
2) adjusted for lifestyle (at least one lifestyle variable, such
as smoking, body mass index, exercise, weight; some
studies adjusted simultaneously for one or more de-
mographic variables); 3) adjusted for illness-related vari-
ables indicating the severity of a disorder or the presence
and severity of comorbid disorders (with or without
simultaneous adjustment for demographic variables);
and 4) adjusted for lifestyle and illness-related factors. As
can be seen in Table 4, the overall relative risk decreased
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TABLE 2. Unadjusted Relative Risk of Excess Mortality in Depressed Compared With Nondepressed Participantsa
Heterogeneityb
Analysis and Measure N Relative Risk 95% CI I2 95% CI p
Unadjusted analyses
All studies 238 1.64 1.56–1.72 83*** 80–84
18 outliers excludedc 220 1.58 1.51–1.65 82*** 79–84
Adjusted for publication bias (number of ﬁlled studies, 41) 1.52 1.45–1.59
Outcomes for speciﬁc groups 0.047
Community samples 78 1.59 1.47–1.71 90*** 89–92
Heart disease patients 65 1.72 1.56–1.90 73*** 66–79
Cancer patients 23 1.61 1.37–1.88 50** 19–69
Kidney disease patients 14 1.66 1.35–2.03 36 0–66
Chronic obstructive pulmonary disease patients 7 2.72 1.96–3.77 81*** 63–91
Diabetes patients 6 1.61 1.21–2.15 25 0–69
Stroke patients 5 1.26 0.92–1.72 66* 10–87
Mixed patient groups 17 1.51 1.25–1.82 70*** 52–82
Other patient groupsd 9 1.69 1.26–2.28 55* 6–79
Nursing home residents 9 1.61 1.27–2.03 32 0–69
Case-control studies 5 2.51 1.65–3.81 0 0–79
Other subgroup analyses
Deﬁnition of depression 0.97
Diagnostic interview 72 1.64 1.49–1.80 67*** 57–74
Self-report measure 166 1.64 1.56–1.73 85*** 84–87
Prevalence of depression 0.38
,10% 33 1.77 1.56–2.01 75*** 66–82
10%–19% 60 1.65 1.51–1.80 90*** 87–92
20%–29% 58 1.58 1.44–1.73 78*** 72–83
30%–40% 32 1.80 1.57–2.06 73*** 61–81
.40% 38 1.56 1.38–1.76 72*** 62–80
Not reported 17 1.51 1.26–1.81 37 0–65
Follow-up periode ,0.01
#1 year 51 1.83 1.63–2.06 33* 5–53
1–2 years 38 1.79 1.58–2.02 62*** 47–74
3–5 years 64 1.73 1.59–1.88 73*** 65–79
5–10 years 59 1.61 1.49–1.74 88*** 86–90
.10 years 24 1.29 1.15–1.44 86*** 80–90
Outcome statistic 0.74
Hazard ratio 68 1.69 1.56–1.84 78*** 72–82
Relative risk based on numbers 152 1.61 1.52–1.70 78*** 75–81
Relative risk (given in study) 11 1.59 1.30–1.96 79*** 63–88
Odds ratio 7 1.59 1.20–2.11 44 0–77
Country 0.08
United States 90 1.58 1.47–1.70 74*** 68–79
European countries 92 1.74 1.62–1.87 84*** 81–87
Other Western countries 25 1.42 1.24–1.63 85*** 79–89
East Asian countries 19 1.72 1.46–2.04 73*** 58–83
Other countries 12 1.76 1.34–2.30 43 0–71
Risk of bias 0.04
1 (highest) 8 2.44 1.81–3.28 0 0–68
2 31 1.72 1.48–2.00 67*** 52–77
3 38 1.77 1.55–2.01 79*** 72–84
4 84 1.61 1.48–1.74 88*** 86–90
5 (lowest) 77 1.57 1.45–1.70 80*** 75–83
a Hazard ratios and odds ratios were treated as if they were relative risks.
b The p value here indicates whether the Q statistic was signiﬁcant.
c Studies with a relative risk $4 or ,0.25 were considered to be outliers.
d In the other patient groups category, we grouped the following studies together: patients with cirrhosis, dementia, hip fracture/surgery, HIV,
liver transplantation, Parkinson’s disease; patients being weaned from prolonged mechanical ventilation; and elderly patients discharged
from a rehabilitation ward after orthopedic surgery on a lower limb.
e Three studies for which the follow-up period was not clear were excluded from these analyses.
* p,0.05. **p,0.01. ***p,0.001.
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somewhat after adjustment for these variables, with a
lower relative risk when more categories of variables were
entered into the models.
There were few indications of signiﬁcant differences
between community and patient samples for adjusted
mortality risks. There was, however, a signiﬁcant differ-
ence between subgroups in the studies in which the results
were adjusted for illness-related factors (p,0.05). In
studies of heart disease patients especially, the relative
risk was higher than in other populations.
Because of the considerable differences between the
variables for which the outcomes were adjusted in
individual studies, the relatively small number of studies
in each of the four categories, and the high level of
heterogeneity of the pooled outcomes, we did not conduct
any additional analyses with these samples.
Discussion
In this meta-analysis we did not ﬁnd strong indications
that excess mortality associated with depression is sig-
niﬁcantly higher in one or more patient groups or in
community-based samples, except for a signiﬁcantly
higher risk in studies of COPD patients. Our observation
that the association between depression and mortality is
not strikingly different between community-based samples
and patient samples suggests that the association between
depression and mortality may be explained better by
generic mechanisms, such as biological dysregulations
and lifestyle factors that have a general impact on health,
than by disorder-speciﬁc mechanisms, such as vascular
endothelial dysfunction, stimulated tumor growth, or
increased platelet aggregation.
It is not clear why the studies of COPD patients resulted
in a higher risk of mortality than those of other (patient
and community-based) samples. It is possible that this
is a chance ﬁnding, because the number of studies was
relatively low (N=7). However, it is also possible that this
ﬁnding is related to COPD-related variables, such as
airﬂow limitation, hypercapnia, hypoxemia, increased
dyspnea, and poor nutritional status, all of which have
been found to be risk factors for mortality in COPD
patients (24), which in turn may somehow be related to
depression.
The fact that formost categories of studies no signiﬁcant
differences were found in mortality rates according to
depression status should be considered with caution. The
speciﬁc patient groups may not be as distinct as they
appear, as these patients may very well have suffered from
all kinds of comorbidities. Quite a few patients with cancer
also have heart disease, and many patients with diabetes
also have renal disease. Thus, deaths occurring in these
populations may not be related to the disease being
studied but to a comorbid disease. For example, cardiac
death is common among diabetes patients. In addition,
even when mortality rates are comparable in different
populations, that does not automatically mean that the
mechanisms leading to death are the same in the different
FIGURE 2. Funnel Plot of Standard Error by Log Relative Risk of Excess Mortality in Adult Depression: Actual and Imputed
Studiesa
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a The white circles indicate actual studies, and the green circles indicate the imputed studies—those that would have been there if the funnel
plot had been symmetrical. The vertical line represents the pooled log relative risk after adjustment for publication bias. The diagonal lines
represent the borders of the funnel plot.
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populations. For example, nonadherence to medication
use may be life-threatening in one population but not in
another, and elevations of a particular inﬂammatory marker
may have different implications for a cancer patient than for
a patient with heart disease.
We also found in our meta-analysis that heterogeneity of
the pooled relative risk was considerable. This suggests that
other factors that we did not examine in this meta-analysis
had a considerable inﬂuence on the outcomes, and we
cannot rule out the possibility that some of these factors are
disease speciﬁc. It is also possible that the heterogeneity
may be explained in part by depression-related variables
that we did not measure, such as severity, number of
depressive episodes, and duration of illness. However, in
this context it is remarkable that we did not ﬁnd any
signiﬁcant differences in the excess mortality rates for
psychiatric diagnoses of depression, which are generally
more severe, than for self-reported symptoms of depres-
sion, which often indicate subthreshold depression (25).
Therefore, more research is needed to establish the exact
mechanisms connecting depression and excess mortality.
This meta-analysis conﬁrmed that there is a highly
signiﬁcant association between depression and excess
mortality at follow-up. However, we found indications
that this association may have been overestimated in
earlier research because of publication bias and because
of a stronger association between depression and excess
mortality in studies of lower quality. Despite the likely
overestimation, the association remains highly signiﬁ-
cant, even after adjustment for publication bias and low
quality.
This study showed once again that depression is an
important clinical and public health problem. Because of
the high prevalence of depression, the associated excess
mortality may have a high impact on public health. An
earlier study (25) found, for example, that the population
attributable fraction of major depression was 10%, in-
dicating that mortality rates would go down 10% if de-
pression could be eliminated completely. For clinicians, it
is also important to realize that depression is associated
with excess mortality, and the assessment of physical
health in depressed patients is always important.
Prevalence rates of depression may vary, with higher
rates in patient groups than in community samples. When
the prevalence of depression is higher, the public health
impact on mortality is also higher (i.e., higher population
TABLE 3. Multivariate Meta-Regression Analyses of Study Characteristics and Effect Sizes
Full Model Parsimonious Modela
Coefﬁcient SE p Coefﬁcient SE p
Group
Heart disease patients Reference
Cancer patients –0.07 0.10 0.50
Kidney disease patients –0.12 0.12 0.33
Chronic obstructive pulmonary disease patients 0.39 0.19 0.04 0.48 0.18 0.008
Other patient groups –0.09 0.08 0.23
Other populations 0.14 0.15 0.35
Community samples –0.05 0.07 0.50
Diagnostic interview (versus self-report measure) –0.07 0.06 0.25
Prevalence of depressionb –0.002 0.002 0.21
Follow-up periodb –0.02 0.004 ,0.001 –0.01 0.004 ,0.001
Outcome statistic
Hazard ratio Reference
Relative risk based on numbers –0.12 0.06 0.05
Relative risk (given in study) 0.06 0.13 0.65
Odds ratio –0.18 0.16 0.27
Country
United States Reference
European countries 0.05 0.06 0.44
Other Western countries –0.09 0.08 0.27
East Asian countries 0.05 0.10 0.63
Other countries 0.07 0.14 0.61
Risk of biasb –0.07 0.03 0.01 –0.07 0.02 0.005
Publication yearb ,–0.001 0.004 0.88
Constant 2.41 8.78 0.78 0.83 0.10 ,0.001
a In the parsimonious model, the least signiﬁcant variable was dropped in each step of a backward regression analysis, until only signiﬁcant
predictors (p,0.05) were retained.
b Entered in the model as continuous variables.
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attributable risk), although the relative risk is the same in
higher- and lower-prevalence populations.
This study has several strengths and limitations. The
major strength is its broad scope and the large number of
included studies and participants, which allowed us to
directly examine whether excess mortality is comparable
across different populations. At the same time, however,
this is also one of the limitations of the study. Such a broad
scope inevitably results in high levels of heterogeneity, and
wewere unable to identify the causes that can fully explain
this heterogeneity. Another limitation is that the quality of
many of the included studies was not optimal, and this
may have affected our outcomes, especially since we
found a signiﬁcant association between study quality and
outcome.
Despite these limitations, however, this study has once
again conﬁrmed a signiﬁcant association between de-
pression and excess mortality at follow-up. This excess
mortality is comparable in community samples and most
patient populations, and although the evidence is not
conclusive, this suggests that generic and not disease-
speciﬁc mechanisms may be the most likely mechanisms
for the excess mortality among depressed persons.
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